Literature DB >> 29393129

The Burden of Acute Kidney Injury and Related Financial Issues.

Marlies Ostermann, Jorge Cerdá.   

Abstract

BACKGROUND: Acute kidney injury (AKI) is one of the most common complications in acutely ill patients. The epidemiology, clinical presentation, and outcome vary between patients and countries.
SUMMARY: Patients with AKI often exhibit multiple organ dysfunction that is caused, in part, by marked cross-talk between the kidney and other organs and tissues. These deleterious interactions arise, at least in part, from systemic inflammatory changes, an increased cytokine load, increases in leukocyte trafficking and activation of neurohormonal processes. Typical short-term complications of AKI include acute lung injury, liver dysfunction, cardio-renal syndrome, brain dysfunction, systemic inflammation, and increased mortality. Survivors of AKI are at risk of chronic kidney disease, cardiovascular morbidity, strokes, infections, bone fractures and increased mortality. AKI is associated with high healthcare costs as a result of a longer stay in hospital, increased costs for investigations and interventions and the development of long-term complications including dialysis dependence, chronic comorbidities and re-hospitalisations. The outcomes and financial implications are worse in low-income countries compared to high-income countries. Key Message: AKI is common among hospitalised patients and associated with serious short- and long-term complications, increased mortality, and high health care costs. There are important differences in epidemiology and outcomes between low- and high-income countries.
© 2018 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2018        PMID: 29393129     DOI: 10.1159/000484967

Source DB:  PubMed          Journal:  Contrib Nephrol        ISSN: 0302-5144            Impact factor:   1.580


  7 in total

Review 1.  Pannexins in Acute Kidney Injury.

Authors:  Nabin Poudel; Mark D Okusa
Journal:  Nephron       Date:  2019-06-26       Impact factor: 2.847

2.  Under-recognized post-stroke acute kidney injury: risk factors and relevance for stroke outcome of a frequent comorbidity.

Authors:  Fabrizio Grosjean; Michela Tonani; Rosario Maccarrone; Carlo Cerra; Federica Spaltini; Annalisa De Silvestri; Francesco Falaschi; Simona Migliazza; Carmine Tinelli; Teresa Rampino; Antonio Di Sabatino; Alessandra Martignoni
Journal:  Int Urol Nephrol       Date:  2019-06-20       Impact factor: 2.370

3.  AKI!Now Initiative: Recommendations for Awareness, Recognition, and Management of AKI.

Authors:  Kathleen D Liu; Stuart L Goldstein; Anitha Vijayan; Chirag R Parikh; Kianoush Kashani; Mark D Okusa; Anupam Agarwal; Jorge Cerdá
Journal:  Clin J Am Soc Nephrol       Date:  2020-04-21       Impact factor: 8.237

4.  Urinary [TIMP-2] × [IGFBP7] and serum procalcitonin to predict and assess the risk for short-term outcomes in septic and non-septic critically ill patients.

Authors:  Ilaria Godi; Silvia De Rosa; Francesca Martino; Simona Bazzano; Marina Martin; Elisa Boni; Maria Rosa Carta; Claudia Tamayo Diaz; Gaia Mari; Anna Lorenzin; Massimo de Cal; Valentina Corradi; Carlotta Caprara; Davide Giavarina; Claudio Ronco
Journal:  Ann Intensive Care       Date:  2020-04-21       Impact factor: 6.925

5.  Association of plasma and urine NGAL with acute kidney injury after elective colorectal surgery: A cohort study.

Authors:  Nuttha Lumlertgul; Marlies Ostermann; Stuart McCorkell; Jonathan van Dellen; Andrew B Williams
Journal:  Ann Med Surg (Lond)       Date:  2021-01-22

Review 6.  Acute Kidney Injury (AKI) in Young Synthetic Cannabinoids Abusers.

Authors:  Stefano D'Errico; Martina Zanon; Davide Radaelli; Monica Concato; Martina Padovano; Matteo Scopetti; Paola Frati; Vittorio Fineschi
Journal:  Biomedicines       Date:  2022-08-10

7.  Cumulative fluid accumulation is associated with the development of acute kidney injury and non-recovery of renal function: a retrospective analysis.

Authors:  Jing Zhang; Siobhan Crichton; Alison Dixon; Nina Seylanova; Zhiyong Y Peng; Marlies Ostermann
Journal:  Crit Care       Date:  2019-12-03       Impact factor: 9.097

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.